How do healthcare workers in diagnostic imaging minimise risks but maximise performance during the COVID‐19 pandemic?

Field	Value	Language
dc.contributor.author	Basseal, Jocelyne M.	en
dc.contributor.author	Collignon, Peter	en
dc.date.accessioned	2020-06-18
dc.date.available	2020-06-18
dc.date.issued	2020	en
dc.identifier.uri	https://hdl.handle.net/2123/22566
dc.description.abstract	The severe acute respiratory syndrome coronavirus (SARS‐CoV‐2), the causative agent of COVID‐19, is a lipid‐layer enveloped RNA virus, capable of infecting receptor‐expressing epithelial cells. The angiotensin‐converting enzyme 2 (ACE2) molecule has been identified as the attachment molecular for SARS‐CoV‐2 as well as for SARS‐CoV and the human coronavirus hCoV‐NL63.ACE2 is expressed to varying degrees by the cells of the upper and lower respiratory tract, stomach, intestine, kidney and the central nervous, circulatory and reproductive systems.	en
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	How do healthcare workers in diagnostic imaging minimise risks but maximise performance during the COVID‐19 pandemic?	en
dc.type	Article	en
dc.identifier.doi	10.1002/ajum.12207
usyd.faculty	Faculty of Medicine and Health, Sydney Medical School	en

Associated file/s

There are no files associated with this item.